Arvinas, Inc. Profile Avatar - Palmy Investing

Arvinas, Inc.

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera…

Biotechnology
US, New Haven [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Arvinas, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Arvinas, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Arvinas, Inc..

End of ARVN's Analysis
CIK: 1655759 CUSIP: 04335A105 ISIN: US04335A1051 LEI: - UEI: -
Secondary Listings
ARVN has no secondary listings inside our databases.